Article

Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: A case report and literature review.

2022-04-18

Abstract excerpt

<h4>Background: </h4> The standard treatment for locally advanced rectal cancer (LARC) is preoperative chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. However, it has been suggested that intensification of neoadjuvant treatment with polychemotherapy added before CRT instead of as an adjuvant chemotherapy is better tolerated and associated with a higher pathological complete response (pCR) ra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e73c6b7d-145e-555c-af56-f886f02885f4
DOI: 10.21203/rs.3.rs-1549402/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: A case report and literature review.DOI 10.21203/rs.3.rs-1549402/v1Read

Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety.Semantic proximity Read

Multiple rectal carcinomas successfully treated by intersphincteric resection with neoadjuvant therapy without radiation therapy: A case reportSemantic proximity Read

Rectal cancer.Semantic proximity Read

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).Semantic proximity Read

Rare but Marvelous Efficacy of Neoadjuvant Chemotherapy for Adenocarcinoma of Rectum: A Case ReportSemantic proximity Read

[Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].Semantic proximity Read

Neoadjuvant Combination Immunotherapy for Colorectal Cancer: Clinical and Molecular Predictors of Pathological Complete Response and Safety AssessmentSemantic proximity Read

Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity Read

Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal CancerSemantic proximity Read

Adjuvant chemotherapy for poor-responders to neoadjuvant therapy in locally advanced rectal cancer: does it improve the prognosis?Semantic proximity Read

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapySemantic proximity Read

Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited SettingSemantic proximity Read